Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce.

@article{Das2002UsingTM,
  title={Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce.},
  author={Priyadarshini Das and Minshan Chen and Kristin J Valentine and Lynn Lopes and Robert A. Cormack and Andrew A Renshaw and Clare M. Tempany and Sanjaya Kumar and Anthony V. D'Amico},
  journal={International journal of radiation oncology, biology, physics},
  year={2002},
  volume={54 3},
  pages={
          698-702
        }
}
PURPOSE To identify events that precipitated a prostate-specific antigen (PSA) bounce and characterize the magnitude, duration, and time to PSA bounce after MRI-guided prostate brachytherapy. METHODS AND MATERIALS Between 1997 and 2001, 186 patients with low-risk prostate cancer underwent MRI-guided permanent 125I source implantation, with or without external beam radiotherapy. A PSA bounce was defined as a >or=15% elevation in PSA compared with the most recent value, followed by a decline to… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

Similar Papers

Loading similar papers…